Wandercraft, a Paris-based robotics company, is seeking approximately €100 million (around $116 million) in new equity funding to enhance the commercialization of its hardware platforms. The firm is collaborating with Goldman Sachs Group Inc. to facilitate this funding round, which is expected to achieve a pre-money valuation of about €750 million. Discussions are ongoing, and neither Wandercraft nor Goldman Sachs has commented on specific terms or timelines.
This funding initiative comes as Wandercraft transitions from its specialized rehabilitation hardware to a focus on heavy industrial automation. The company previously raised $75 million in a Series D funding round, which included investments from Renault SA and other notable entities. Wandercraft is known for its dynamic balancing medical exoskeletons, but its recent efforts are centered on the Calvin family of industrial humanoids designed for heavy-payload material handling in automotive manufacturing.
Looking ahead, Wandercraft's push for €100 million reflects a larger trend in European robotics financing, where startups are increasingly attracting significant late-stage investments. The involvement of Goldman Sachs indicates a shift towards institutional investors capable of supporting long-term manufacturing cycles, as seen in recent funding successes by other European robotics firms like NEURA Robotics and Humanoid.
Editor's Note
Wandercraft's pursuit of substantial funding underscores the growing interest in industrial automation within the robotics sector. As European startups attract late-stage capital, the competitive landscape is shifting, with institutional investors playing a more prominent role. This trend may influence how companies approach scaling and innovation in robotics and automation technologies.
Leave a comment